Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07035834
What this trial is testing

SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis

Who this might be right for
Lupus Nephritis (LN)ANCA Associated Vasculitis (AAV)
Federico II University 40
Not applicableStudy completedNCT02500186
What this trial is testing

The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor

Who this might be right for
Diabetes Melltius, Type 2
Kansai Electric Power Hospital 24
Very early researchEnded earlyNCT06124924
What this trial is testing

SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

Who this might be right for
Acute Kidney Injury
University of Minnesota 1
Large-scale testing (Phase 3)Study completedNCT05606913
What this trial is testing

IBI362 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Innovent Biologics (Suzhou) Co. Ltd. 731
Not applicableActive Not RecruitingNCT05999773
What this trial is testing

SGLT-2 Inhibitors in the Treatment of Ascites

Who this might be right for
Ascites HepaticCirrhosis, LiverDiabete Type 2
University of Palermo 40
Not applicableStudy completedNCT05986695
What this trial is testing

Informational Nudge to Improve Heart Failure Prescribing

Who this might be right for
Heart Failure
VA Office of Research and Development 81
Not applicableStudy completedNCT07332156
What this trial is testing

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Who this might be right for
Type 2 DiabetesCOPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis)
Samsung Medical Center 21,692
Not applicableUnknownNCT05047471
What this trial is testing

To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Kidney Disease
Yiming Mu 10,000
Post-approval studies (Phase 4)Study completedNCT03485222
What this trial is testing

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

Who this might be right for
Cardiovascular Diseases
Icahn School of Medicine at Mount Sinai 84
Testing effectiveness (Phase 2)Looking for participantsNCT06528405
What this trial is testing

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Who this might be right for
Acute Kidney Injury
National Taiwan University Hospital 264
Not applicableStudy completedNCT04061473
What this trial is testing

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Who this might be right for
Diabetes After Total Pancreatectomy
University Hospital, Gentofte, Copenhagen 20
Not applicableStudy completedNCT04735042
What this trial is testing

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Who this might be right for
Type 2 DiabetesUrinary Tract Infections
University of Pisa 60
Not applicableActive Not RecruitingNCT07084038
What this trial is testing

Effect of Glycosuria on Urinary Protein in Patients With Chronic Kidney Disease Treated With SGLT2 Inhibitors

Who this might be right for
Chronic Kidney Disease
Yuanjun Yang 300
Large-scale testing (Phase 3)Study completedNCT06649344
What this trial is testing

HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 884
Post-approval studies (Phase 4)Looking for participantsNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Post-approval studies (Phase 4)Looking for participantsNCT07482943
What this trial is testing

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Who this might be right for
FontanHeart FailureDapagliflozin+2 more
The University of Hong Kong 30
Not applicableNot Yet RecruitingNCT07723820
What this trial is testing

Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Retinopathy (DR)
Thammasat University Hospital 126
Not applicableNot Yet RecruitingNCT06637618
What this trial is testing

Does the Sequence of Heart Failure Medication Matter

Who this might be right for
Heart Failure, Reduced Ejection Fraction
Aarhus University Hospital 16,000
Not applicableStudy completedNCT05993897
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

Who this might be right for
Atrial Fibrillation
Aswan University 60
Large-scale testing (Phase 3)Study completedNCT03968224
What this trial is testing

Effectiveness of Dapagliflozin for Weight Loss

Who this might be right for
PreDiabetesObesity, MorbidDiabetes Mellitus, Type 2
Centro Medico Nacional Siglo XXI IMSS 160
Next Page